Results 1 to 10 of about 28,606 (286)

History of the Surveillance, Epidemiology, and End Results (SEER) Program [PDF]

Journal of the National Cancer Institute Monographs
Abstract The Surveillance, Epidemiology, and End Results (SEER) Program established in 1973 was the first laboratory for experimenting with new methods for cancer data collection and translating the data into population-based cancer statistics.
Şerban Negoita, Negoita Şerban
exaly   +4 more sources

Toward real-time reporting of cancer incidence: methodology, pilot study, and SEER Program implementation [PDF]

Journal of the National Cancer Institute Monographs
Abstract Background A lag time between cancer case diagnosis and incidence reporting impedes the ability to monitor the impact of recent events on cancer incidence. Currently, the data submission standard is 22 months after a diagnosis year ends, and the reporting standard is 27.5 months after a ...
Huann-Sheng Chen, Şerban Negoita, Elizabeth Hsu   +2 more
exaly   +4 more sources

The epidemiology and prognosis of patients with primary gastric T-cell lymphoma in the SEER program. [PDF]

Cancer Med, 2023
AbstractBackgroundPrimary gastric T‐cell lymphoma (PG‐TCL) is a rare hematological malignancy with few data reported. The objective of this study is to investigate the epidemiology, clinical characteristics, and survivals of PG‐TCL.MethodsTotally, 164 patients with PG‐TCL from 1975 to 2016 extracted from the Surveillance, Epidemiology, and End Results ...
Zhang M, Xiao F, Lin M, Chen M, Hou J, Huang H.   +5 more
europepmc   +4 more sources

Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program. [PDF]

J Am Acad Orthop Surg Glob Res Rev, 2022
Introduction: The US Military Health System (MHS) provides universal health care to beneficiaries. Few studies have evaluated the potential influence of access to universal care on survival outcomes for sarcoma. This study compared the survival of adult patients with soft-tissue sarcoma in the MHS with the US general population.
Anderson AB, Park AB, Zhu K, Lin J, Shriver CD, Potter BK.   +5 more
europepmc   +3 more sources

How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology

Military Medical Research, 2023
In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. This program aims
Wen-Qiang Che, Yuan-Jie Li, Chi-Kwan Tsang, Yu-Jiao Wang, Zheng Chen, Xiang-Yu Wang, An-Ding Xu, Jun Lyu   +7 more
doaj   +2 more sources

Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program. [PDF]

Sci Rep, 2020
AbstractTo compare the clinicopathological characteristics and survival outcomes of children and adult diagnosed with medullary thyroid carcinoma (MTC). MTC patients were extracted from the Surveillance, Epidemiology and End Results (SEER) database from 1998 to 2016, followed by stratification into pediatric (< 20 years) or adult (≥ 20 years) groups.
Zhao Z, Yin XD, Zhang XH, Li ZW, Wang DW.   +4 more
europepmc   +3 more sources

Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015). [PDF]

Eur J Haematol, 2020
AbstractObjectivePrimary renal lymphoma (PRL) is defined as a non‐Hodgkin lymphoma (NHL) restricted to kidneys without extensive nodal disease. The literature on epidemiology and outcome in PRL is limited to case reports and small case series.MethodsWe utilized Surveillance, Epidemiology, and End Result database (1984‐2015) to study the demographic ...
Taneja A, Kumar V, Chandra AB.
europepmc   +4 more sources

Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER Program. [PDF]

BMC Gastroenterol, 2023
Abstract Background This study will focus on exploring the clinical characteristics of rectal cancer (RC) patients with Second Primary Malignancies (SPMs) and constructing a prognostic nomogram to provide clinical treatment decisions.
Sun YC, Zhao ZD, Yao N, Jiao YW, Zhang JW, Fu Y, Shi WH.   +6 more
europepmc   +4 more sources

Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry

Cancer Medicine, 2023
Background Military individuals, retirees, and their families have free care or minimal out‐of‐pocket costs in the US military health system (MHS). In contrast, out‐of‐pocket costs in the US general population vary substantially.
James T. Flanary, Jie Lin, Craig D. Shriver, Kangmin Zhu   +3 more
doaj   +2 more sources

The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship. [PDF]

Am J Surg Pathol, 2016
The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately 30% of the United States (US) population. To reflect advances in research and oncology practice, approaches to cancer control are evolving from simply enumerating the development of
Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME.   +4 more
europepmc   +4 more sources